U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07603284) titled 'Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia' on May 18.
Brief Summary: This study aims to understand how using real-time continuous glucose monitoring (RT-CGM) can help people with Type-2 diabetes on insulin in Saudi Arabia.
Study Start Date: Nov. 24, 2025
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes on Insulin
Intervention:
DEVICE: Real-Time Continuous Glucose Monitoring
real time continuous glucose monitoring utilizing a CGM
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: DexCom, Inc.
Disclaimer: Curated by HT Syndication....